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Abstract
Background: Type III secretion system is a virulent factor for many pathogens, and is thought to play multiple roles in the
development cycle and pathogenesis of chlamydia, an important human pathogen. However, due to the obligate
intracellular parasitical nature of chlamydiae and a lack of convenient genetic methodology for the organisms, very limited
approaches are available to study the chlamydial type III secretion system. In this study, we explored the reconstitution of a
chlamydial type III secretion in Escherichia coli.
Results: We successfully cloned all 6 genomic DNA clusters of the chlamydial type III secretion system into three bacterial
plasmids. 5 of the 6 clusters were found to direct mRNA synthesis from their own promoters in Escherichia coli transformed
with the three plasmids. Cluster 5 failed to express mRNA using its own promoters. However, fusion of cluster 5 to cluster 6
resulted in the expression of cluster 5 mRNA. Although only two of the type III secretion system proteins were detected
transformed E. coli due to limited antibody availability, type III secretion system-like structures were detected in ultrathin
sections in a small proportion of transformed E. coli.
Conclusions: We have successfully generated E. coli expressing all genes of the chlamydial type III secretion system. This
serves as a foundation for optimal expression and assembly of the recombinant chlamydial type III secretion system, which
may be extremely useful for the characterization of the chlamydial type III secretion system and for studying its role in
chlamydial pathogenicity.
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Introduction
Gram-negative bacterial pathogens use the type III secretion
(T3S) system (T3SS) to communicate with their eukaryotic host
cells [1]. Upon physical contact of bacteria with host cells,
bacterial cytosolic proteins referred to as T3S effectors are
translocated to the eukaryotic cells through a needle-like structure
referred to as ‘‘injectisome’’. In addition to the needle connecting
the bacterium and the eukaryotic cell, the injectisome consists of
ring-like structures on the bacterial inner and outer membranes,
and a pore-like structure made of proteins designated translocators
on the target eukaryotic cell membrane.
The inner diameter of the T3SS needle is about 2.5 nm,
permitting the passage of only unfolded proteins [2]. Emerging
evidence suggests that prior to transportation many T3S effectors
exist in partially unfolded conformation and are associated with
T3SS protein chaperones, which keep the effectors from being
degraded in the bacterial cytosol. Hydrolysis of ATP by the T3SS
ATPase, located at the cytoplasmic interface of the basal body,
causes the dissociation of T3S effectors from their chaperones. The
energy provided by the ATPase is also used to (further) unfold the
effectors, allowing them to enter and travel through the narrow
needle [1,3,4,5,6].
Though the overall structure of the T3SS injectisome is highly
alike among various organisms, T3S plays distinct roles in the
pathogenesis of different infections. Pathogenic Yersinia spp secrete
outer proteins designated Yops, which inhibit phagocytosis of
macrophages and neutrophils, thus permitting their extracellular
survival and replication [7]. In contrast, Salmonella spp use a T3SS
encoded to mediate the uptake of bacterium into the host cell [8].
Inside the cell, another T3SS is activated, causing the rupture of
Salmonella-containing vacuoles and the release of bacteria into the
cytoplasm [9].
Chlamydia is an obligate intracellular bacterium that is respon-
sible for or contributes to a number of human diseases including
sexually transmitted infection, preventable blindness, respiratory
tract infection, and arteriosclerosis [10,11]. Chlamydia has a unique
developmental cycle, which alternates between two cellular forms:
the infectious but metabolically-inert elementary body (EB) and
the vegetative but non-infectious reticulate body (RB) [12]. The
developmental cycle starts with the attachment of an EB to the
host cell plasma membrane. The EB is taken up into a vacuole
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designated an inclusion. Inside the inclusion, the EB develops into
the dividing RB. After successive binary fissions, most RBs
differentiate back into EBs before the completion of the
developmental cycle and the release of chlamydiae from the host
cell [13,14].
Similar to most other Gram-negative pathogens, Chlamydia
encodes a T3SS. The chlamydial T3SS (cT3SS) is thought to form
projections on the chlamydial cell surface detected with electron
microscopy [15,16] . cT3SS appears to play multiple roles
throughout the chlamydial developmental cycle [[17,18] for
review]. Thus, immediately upon cell entry, EBs secrete TARP,
a T3S effector, into the cytoplasm. By recruiting actin to the site of
EB internalization, secreted TARP enables the trafficking of the
early chlamydial inclusions [19,20,21]. In later stage points, RBs
secrete a variety of protein via the T3SS to the inclusion
membrane or host cell cytoplasm [22,23,24,25,26,27]. The
importance of chlamydial T3S has been implicated by abnormal
intracellular development as results of inhibition of the T3S or the
effectors [24,28,29].
Investigation of chlamydial T3S, to a large degree, has relied on
the use of small T3S inhibitors [24,28,29] and/or surrogate T3SSs
[30,31,32] because of the obligate intracellular nature of the
organism and a lack of a convenient genetic manipulation system.
While these approaches have yielded valuable information for the
cT3SS, they both have limitations. Therefore, even though small
T3SS inhibitors demonstrate specificity in targeting T3S in free-
living bacteria, interpretation of their effects on Chlamydia is
complicated by their significant toxicity to the host cell and by the
reversal of the effects on both the host cell and cT3S with iron ions
[33]. A surrogate system may not operate the same way as the
cT3SS. For example, the chlamydial T3S chaperones Scc2 and
Scc3 fail to fully complement the deficiency of its Yersinia homolog
sycD [30]. In addition, the chlamydial T3S effectors CopD and
Pkn5 cannot be secreted by the T3SS encoded by the pathogenic
island-1 although they can be translocated by the one encoded by
the pathogenic island-2 [32]. The limited availability of research
tools calls for the development of new approaches to studying
chlamydial T3S. The aim of this work is to explore the possibility
of reconstituting cT3SS in E. coli. We cloned all the 6 cT3SS-
encoding clusters into three plasmids, and derived E. coli that
expresses genes from all the 6 clusters concurrently. We further
present evidence for the assembly of T3SS proteins into a
hypothetical T3SS structure despite low efficiency.
Materials and Methods
Strains
C. trachomatis serovar D (strain UW-3/Cx) and serovar L2 (strain
434/bu) were purchased from ATCC. Transformation-competent
E. coli stbl2 was purchased from Stratagen.
Reagents
Primers used for vector construction (Table S1), DNA
sequencing (Table S2) and/or reverse-transcriptase PCR (RT-
PCR) (Table S3) were custom-synthesized at Sigma-Aldrich.
PfuUltra II Fusion HS DNA polymerase was purchased from
Stratagen. DNA endorestriction enzymes, T4 DNA ligase and Taq
DNA polymerase were purchased from New England Biolabs.
The TaqMan RT-PCR kit was purchased from Applied
Biosystems. Monoclonal anti-Flag M2 antibody was purchased
from Sigma-Aldrich. Rabbit polyclonal anti-TARP was generously
provided by Dr. Ted Hackstadt (Rocky Mountain Laboratories,
National Institutes of Health). All other primary antibodies were
generous gifts from Dr. Guangming Zhong (University of Texas
Health Sciences Center at San Antonio).
Molecular cloning
A total of 19 plasmids, 12 for cT3SS and 7 for cT3S effectors,
were constructed for this study (Table 1). Four final plasmids that
were used for expression and characterization of cT3SS expression
in E. coli are highlighted in Table 1 and shown in Fig. 1. In
general, DNA fragments of cT3SS clusters and T3S effector genes
were amplified from the genomic DNA of C. trachomatis D using
the high fidelity PfuUltra II Fusion HS DNA polymerase for PCR
and primers carrying appropriate endorestriction enzyme cutting
sites. PCR products were gel-purified, digested with an endor-
estriction enzyme and cloned into an appropriate vector.
Sequence authenticity of inserts was confirmed by customer
DNA sequencing at Genewiz. Specifically, cluster 2 (nt 628831-
636379) was directly cloned into the SalI site of pACYC184 to
yield plasmid pcT3SS-C2 (Table 1). Cluster 3 (nt 648613-652718)
was amplified with primers each carrying a BstZ17I site and a SalI
site. The PCR product was first cloned into the SalI site of
pBluescript II KS+, and then copy-pasted into the BstZ17I site of
pcT3SS-C2 to yield pcT3SS-C2/C3 (Table 1 and Fig. 1A).
Cluster 4 (nt 760280-773414) was first amplified as two separate
fragments (fC4a of nt 76280-767358 with a ScaI site added to the
59 end, and fC4b of nt 767245-773414 with a ScaI site added to the
39 end) because the 13,135 bp full-length exceeded the amplifi-
cation capacity of the DNA polymerase. fC4a and fC4b were
joined by the T4 ligase following digestion MfeI. The ligation
product was further digested with ScaI and cloned into the ScaI site
of the pACYC184 plasmid to yield pcT3SS-C4 (Table 1 and
Fig. 1B). Cluster 6 (nt 1017829-1012656 in the genomic DNA) was
cloned into the NheI site of pBAD18-kan to yield pcT3SS-C6
(Table 1). Cluster 5 (nt 831936-828219) was then cloned into the
KpnI site of pcT3SS-C6 to yield pcT3SS-C5/C6 (Table 1). Cluster
1 (nt 106660-99851) was first cloned into pBluescript II KS+ using
the SalI site and then moved into pcT3SS-C5/C6 to yield
pcT3SS-C1/C5/C6 (Table 1 and Fig. 1C). pcT3SS-C1/C5-
C6FU represented a variant of pcT3SS-C1/C5/C6. To construct
pcT3SS-C1/C6-C5FU, cluster 6 was fused to nt 831714-828219
of cluster 5 using two-step PCR. The final PCR product was
cloned into pBAD18-kan plasmid to yield pcT3SS-C6-C5FU.
Cluster 1 was transferred from cloned into pcT3SS-C5-C6FU, as
described above, to yield pcT3SS-C1/C6-C5FU (Table 1 and
Fig. 1D).
Expression vectors for five T3S effectors, TARP, IncA, IncD,
IncG and CT813 were constructed with similar strategies
(Table 1). The coding sequence of TARP was first cloned into
pRK5-Flag using NdeI and SalI digestion; the TARP-Flag
sequence was then copy-pasted into pBAD24 between the NdeI
and HindIII sites. To generate expression vectors for the other T3S
effectors, the TARP coding sequence in the pBAD24_TARP-Flag
vector was released by NdeI and SalI double digestion and replaced
by the coding sequences of IncA, IncD, IncG or CT813. Similar to
pBAD24_TARP-Flag, the additional T3S vectors carried an in-
frame Flag tag-coding sequence at the 39-terminus. Sequence
authenticity was confirmed by sequencing. Finally, to obtain an
expression vector for non-tagged TARP, its open reading frame
(including the stop codon) was cloned into pBAD24 between the
NdeI and SalI sites.
Reverse transcriptase PCR (RT-PCR)
E. coli was cotransformed with the three cT3SS expression
vectors and selected on an LB Agar plate containing chloram-
phenicol, tetracycline and kanamycin. LB broth was inoculated
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Figure 1. cT3SS expression vectors. Plasmids in panels A–D contain different cT3SS clusters. The tetracycline-resistance gene (tet) and
chloramphenicol-resistance gene (cml) are inactivated in A and B, respectively, as results of the insertion of cT3SS fragments. Thick black arrows show
cT3SS genes, as numbered in the C. trachomatis serovar D genome. Genes of which mRNA was detected by RT-PCR are underlined. Lengths of genes
are not in scale. Line arrows signify locations of promoters and direction of transcription in operons as previously established [39]. Dotted line in C
indicates no detectable transcription from the promoter shown. Transcription from two internal promoters in panels A and B is unlikely to occur in E.
coli (shown in thinner line arrows). The activities of these two promoters were not specifically examined in this study. Endorestriction sites used for
cloning are shown in italics. The orientations of the cT3SS clusters in the plasmids were not determined and are shown arbitrarily.
doi:10.1371/journal.pone.0050833.g001
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with a colony confirmed by PCR to contain all three plasmids, and
cultured overnight in a shaker incubator at 37uC. A 250 ml
overnight culture was used to inoculate 50 ml fresh LB in a 250 ml
culture flask. The bacteria were allowed to grow in a shaker
incubator at 37uC. When the OD600 of the culture reached
0.4,0.5, bacteria were collected by centrifugation, and resus-
pended with 500 ml lysis buffer (0.5% SDS, 20 mM sodium
acetate and 10 mM EDTA in DEPC-treatedwater, pH 4.0). Total
RNA was extracted first with H2O-saturated phenol and then with
chloroform, and precipitated with ethanol precipitation. Contam-
inating DNA was removed by two rounds of digestion with DNase
I, which was then removed by a DNase-inactivating reagent
(Ambion) [34]. cDNA synthesis and amplification were carried out
using a TagMan RT-PCR kit.
Detection of T3S in E. coli
E. coli was cotransformed with the three cT3SS expression
vectors and an expression vector for a cT3S effector (TARP-Flag,
IncA-Flag, IncD-Flag, IncG-Flag or CT813-Flag) and selected on
an LB Agar plate containing chloramphenicol, tetracycline,
kanamycin and ampicillin. LB broth, supplemented with 0.2%
arabinose, was inoculated with a colony confirmed by PCR to
contain all four plasmids, and cultured overnight in a shaker
incubator at 37uC. The overnight culture was diluted with
Dulbecco’s modified Eagle’s medium (DMEM) to 0.3 OD600.
The dilution was divided into 1.6 ml aliquots, to which EGTA
(final concentration: 2 mM), heat-inactivated fetal bovine serum
(FBS, final concentration: 3%), both or neither, was added. The
aliquots were incubated in a 5% CO2 incubator at 37uC for 6 h. A
1.0 ml sample of each culture was centrifuged at 20,000 g at 4uC
for 3 min. The resulting pellet was dissolved in 200 ml SDS-PAGE
sample buffer, and subjected to sonication [35]. The supernatant
was centrifuged again and filtered through a 0.2 mM filter
(Millipore) to remove any residual bacteria. 800 ml of the filtration
was mixed with 200 ml ice-cold 100% (v/v) trichloroacetic acid
(TCA). The mixture was incubated on ice for 1 h and centrifuged
at 20,000 g at 4uC for 30 min. Proteins in the pellet were washed
with 1 ml ice-cold acetone twice, air dried, re-dissolved in 10 ml
SDS-PAGE buffer and resolved by SDS-PAGE along with a 5 ml
sample of bacterial extract. Flag-tagged T3S effectors were
detected by western blotting using the M2 antibody [36].
E. coli was also cotransformed with three cT3SS expression
vectors and an expression vector for non-tagged TARP, and
selected on an LB Agar plate containing chloramphenicol,
tetracycline, kanamycin and ampicillin. LB broth, supplemented
with 0.2% arabinose, was inoculated with a colony confirmed by
PCR to contain all four plasmids, and cultured overnight in a
shaker incubator at 37uC. The overnight culture was subjected to
treatment described above. Alternatively, bacteria were collected
by centrifugation at 20,000 g for 30 min and were then
resuspended in phosphate-buffered saline (PBS) to yield 0.6
OD600. Two 1.6 ml aliquots of the suspension were generated.
CaCl2 was added to one of the aliquots (final concentration of
CaCl2: 2 mM). The aliquots were incubated at 37uC for 30 min
and then centrifuged. Protein in the supernatant was precipitated
by TCA and subjected to western blotting with an anti-TARP
antibody.
Preparation of EBs
Highly purified EBs were prepared following a protocol of
Caldwell et al [37] with modifications. Near-confluent HeLa cell
monolayers were inoculated with a C. trachomatis L2 stock at the
multiplicity of 1 inclusion-forming unit per cell, cultured with
DMEM containing 10% fetal bovine serum (FBS), 20 mg/ml
gentamycin and 1 mg/ml cycloheximide at 37uC for 40 h. Cells
were removed from the plates using a Cell Lifter. All steps from
Table 1. Vector information.
Plasmid Description
pBluescript II-C1 pBluescript II KS+ containing cluster 1, sequenced
pcT3SS-C2 pACYC184 containing cluster 2, sequenced
pBluescript II-C3 pBluescript II KS+ containing cluster 3, sequenced
pcT3SS-C2/C3 pACYC184 containing cluster 2 and cluster 3 from pBluescript II-C3
pBluescript II-C4a pBluescript II KS+ containing cluster 4a, sequenced
pBluescript II-C4b pBluescript II KS+ containing cluster 4b, sequenced
pcT3SS-C4 pACYC184 containing cluster 4 from pBluescript II-C4a and pBluescript II-C4b
pcT3SS-C6 pBAD18-Kan containing cluster 6, sequenced
pcT3SS-C5/C6 pBAD18-Kan containing cluster 6 and cluster 5, sequenced
pcT3SS-C1/C5/C6 pBAD18-Kan containing cluster 1 (from pBluescript II-C1), cluster 5 and cluster 6
pcT3SS-C6-C5FU pBAD18-Kan containing C6-C5FU, sequenced
pcT3SS-C1/C6-C5FU pBAD18-Kan containing cluster 1 and C6-C5FU
pRK5_TARP-Flag TARP coding sequence was inserted between NdeI and SalI of pRK5-cFlag
pBAD24_TARP-Flag C-Flag-TARP was cutted out by NdeI & HindIII from pRK5_TARP-Flag and pasted into pBAD24
pBAD24_IncA-Flag IncA coding sequence replaced TARP coding sequence of pBAD24_TARP-Flag
pBAD24_IncD-Flag IncD coding sequence replaced TARP coding sequence of pBAD24_TARP-Flag
pBAD24_IncG-Flag IncG coding sequence replaced TARP coding sequence of pBAD24_TARP-Flag
pBAD24_CT813-Flag CT813 coding sequence replaced TARP coding sequence of pBAD24_TARP-Flag
pBAD24_TARP TARP ORF placed between NdeI and SalI sites of pBAD24
Vectors used for experiments to determine cT3SS expression and T3S are shown in boldface.
doi:10.1371/journal.pone.0050833.t001
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this point onward were performed either on ice or at 4uC. Cells
were collected by centrifugation at 35,000 g using a Sorvall SS34
rotor, resuspended in sucrose-phosphate-glutamate buffer (SPG)
and disrupted by sonication. Cell nuclei were spun down by
centrifugation at 500 g for 10 min. The chlamydial organisms in
the supernatant were then separated from cell organelles by
ultracentrifugation through 8 ml of 35% (vol/vol) RenoCal at
43,000 g for 60 min using an SW28 Beckman rotor. EBs, RBs and
remaining host components in the pellet were resuspended and
further separated from each other by ultracentrifugation through
40%/44%/52% RenoCal at 50,000 g for 90 min using an SW28
rotor. EBs were collected from the 44%–52% interface, diluted in
SPG [37], centrifuged at 35,000 g for 10 min, washed . Following
two additional washes with SPG, EBs were resuspended in
appropriate buffer for secretion experiments.
Detection of TARP secretion from EBs
Detection of TARP secretion from EBs were carried out
following published procedures [38] with the modification that
freshly purified EBs were immediately used for experiments. EBs
were resuspended in PBS or PBS containing 2 mM CaCl2. 55 ml
EB suspensions in PBS or PBS containing 2 mM CaCl2 was
incubated at 37uC for 30 min, and centrifuged at 20,000 g for
30 min. A 40 ml sample of the supernatant was transferred into
another tube, and centrifuged again. A 25 ml sample of the
supernatant from the second centrifugation was collected for
western blotting. Each assay contained 46108 inclusion-forming
units as determined retrospectively.
Ultrathin section transmission electron microscopy
For analysis at the ultrastructural level, bacteria were fixed in
2% paraformaldehyde/2.5% glutaraldehyde/phosphate buffer,
pH 7.2 for 1 hr at room temperature. Samples were washed in
phosphate buffer and postfixed in 1% osmium tetroxide (Poly-
sciences Inc., Warrington, PA) for 1 hr. Following extensive
washing in dH20, samples were en bloc stained with 1% aqueous
uranyl acetate (Ted Pella Inc., Redding, CA) for 1 hr. Samples
were then dehydrated in a graded series of ethanol and embedded
in Eponate 12 resin (Ted Pella Inc.). Sections of 90 nm were cut
with a Leica Ultracut UCT ultramicrotome (Leica Microsystems
Inc., Bannockburn, IL), stained with uranyl acetate and lead
citrate, and viewed on a JEOL 1200 EX transmission electron
microscope (JEOL USA Inc., Peabody, MA).
Results
cT3SS genes are organized into 6 clusters and 10 operons in the
chlamydial genome [39]. We initially constructed 3 plasmids
carrying the 6 clusters. The first two plasmids were both derived
from pACYC184: one, designated pcT3SS-C2/C3, contained
clusters 2 and 3, of 7,549 bp and 4,106 bp, respectively (Fig. 1A);
the other, designated pcT3SS-C4, contained a single but large
(13,135 bp) cluster 4 (Fig. 1B). The third plasmid, designated
pcT3SS-C1/C5/C6, was a pBAD18-kan derivative, which
contained the remaining three clusters of cT3SS: clusters 1, 5
and 6, of 5,174 bp, 3,718 bp and 6,810 bp, respectively (Fig. 1C).
All cloned clusters carried their native promoters which have been
previously identified [39].
E. coli was co-transformed with the three plasmids and selected
with three antibiotics, chloramphenicol, tetracycline and kanamy-
cin, or with empty pACYC184 and pBAD18. Bacterial extracts
were subjected to western blotting with antibodies for each protein
of the cT3SS [40]. Among the 37 antibodies, only anti-CT557 and
anti-CT672 each detected a protein specifically associated with
cT3SS plasmid transformation (Fig. 2), whereas all other
antibodies failed to demonstrate specificity in western blotting.
The lack of a signal in the control vector-transformed E. coli
suggests that the single protein band detected in the cT3SS-
transformed bacteria shown in Fig. 2A was CT557. This was
further supported by the fact that the protein band had a 49 kDa
molecular mass predicted for CT557. On the other hand, anti-
CT672 detected numerous protein bands in both cT3SS-
transformed E. coli and control bacteria, in addition the protein
Figure 2. Detection of CT557 and CT672 in E. coli transformed
with pcT3SS-C1/C5/C6, pcT3SS-C2/C3 and pcT3SS-C4 by
western blotting. Control bacteria were transformed with empty
pACYC184 and pBAD18 plasmids.
doi:10.1371/journal.pone.0050833.g002
Figure 3. RT-PCR analysis of cT3SS gene transcription in E. coli transformed with pcT3SS-C1/C6-C5FU, pcT3SS-C2/C3 and pcT3SS-
C4. Cluster (C) numbers and operon (O) numbers are shown. Note amplification occurred only in reaction for which cDNA but not RNA was used as
template.
doi:10.1371/journal.pone.0050833.g003
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band seen only in cT3SS-transformed bacteria which migrated as
a 55 kDa protein (Fig. 2B). CT672 had a predicted 41 kDa
molecular mass. Thus, CT672 appears to have a slower-than-
expected gel mobility, similar deviations of actual gel mobility
from the expected mobility based on the molecular mass have
been documented for other proteins by us [41] and others [42].
In the absence of evidence of protein expression from all
clusters, we used RT-PCR to determine the expression of mRNA
of cT3SS clusters in the transformed bacteria. We detected mRNA
encoded by clusters 1–4 and 6 but not cluster 5 (data not shown).
The absence of mRNA expression from cluster 5 is consistent with
previous analysis demonstrating a lack of recognition of the single
promoter of this cluster by E. coli [39]. To allow the expression of
CT716–719 encoded by cluster 5, we removed the Rho-
independent transcription termination signals of cluster 6 and
the promoter of cluster 5 genes in pcT3SS-C1/C5/C6, thereby
generating the pcT3SS-C1/C6-C5FU plasmid (Fig. 1D). The
conversion of pcT3SS-C1/C5/C6 into pcT3SS-C1/C6-C5FU
enabled the expression of cluster 5. Accordingly, E. coli
transformed with pcT3SS-C1/C6-C5Fu, pcT3SS-C2/C3 and
pcT3SS-C4 produced mRNA from all 6 clusters of cT3SS, as
demonstrated by RT-PCR (Fig. 3). For clusters 2 and 4, multiple
pairs of primers were used in RT-PCR, allowing for the detection
of mRNA of all cT3SS operons. The successful amplification of
cDNA with each and every primer pair tested (Fig. 3) suggests that
all cT3SS genes are transcribed in E. coli.
In light of the fact that cluster 5 mRNA could be expressed
when cluster 5 was fused to cluster 6 but not when cluster 5 existed
as an independent operon, we repeated western blotting for
bacteria transformed with pcT3SS-C1/C6-C5FU, pcT3SS-C2/
C3 and pcT3SS-C4 and for control bacterial using antibodies for
cluster 5 proteins. However, these antibodies failed again to detect
a protein specifically associated with cT3SS transformation (data
not shown).
Figure 4. Lack of secretion of cT3S effectors in cT3SS plasmids-transformed E. coli. (A) Secretion of Flag-tagged T3S effectors from E. coli
could not be induced by using DMEM (medium) containing the calcium-depleting reagent EGTA and/or FBS for 6 h. An anti-Flag antibody was used
to detect the C-terminally tagged cT3S effectors. (B) Secretion of non-tagged TARP from E. coli was not induced under the same conditions as in (A).
(C) TARP secretion from EBs suspended in PBS and PBS containing Ca2+. (D) Secretion of non-tagged TARP from E. coli was not detected using PBS or
PBS containing Ca2+.
doi:10.1371/journal.pone.0050833.g004
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We next transformed E. coli with the three cT3SS expression
vectors (pcT3SS-C1/C6-C5Fu, pcT3SS-C2/C3 and pcT3SS-C4)
for all 6 expressible clusters and an expression vector for a cT3S
effector carrying a C-terminal Flag tag (TARP-Flag, IncA-Flag,
IncD-Flag, IncG-Flag or CT813-Flag), and determined if the
effectors can be secreted from the cytoplasm into culture medium.
Bacteria were exposed to conditions similar to those that induced
T3S in enterobateria [43]. However, western blotting analysis
failed to detect the presence of any of the three cT3S effectors in
the medium under any of the conditions (Fig. 4A). Furthermore,
no TARP secretion was detected under these conditions in E. coli
contranformed with the three cT3SS expression vectors and an
expression vector for non-tagged TARP (Fig. 4B).
Our inability to detect secretion of cT3S effector from T3SS-
expressing E. coli prompted us to question the sensitivity of our
detection technique. However, secretion of TARP were readily
detected in EBs incubated in PBS (Fig. 4C) as previously
demonstrated [38]. Similar level of TARP secretion was detected
with PBS containing Ca2+. In contrast, no TARP secretion from
the cT3SS-expressing bacteria was detected in PBS or PBS
Figure 5. T3SS-like structures in E. coli transformed with cT3SS plasmids. Ultrathin section transmission electron microscopy revealed the
presence of channel-like structures between the cytoplasmic membrane and outer membrane in E. coli transformed with pcT3SS-C1/C6-C5FU,
pcT3SS-C2/C3 and pcT3SS-C4 (A–C). T3SS-like structures are shown more clearly in the enlarged images and indicated by arrowheads. These
structures were not evident in ultrathin sections of control bacteria transformed with empty pACYC184 and pBAD18 plasmids (D). Scale bar is equal
to 100 nm.
doi:10.1371/journal.pone.0050833.g005
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containing Ca2+ (Fig. 4D). Taken together, data presented in Fig. 4
suggest that T3S in the recombinant bacteria either did not occur
or was extremely inefficient.
We used ultrathin section transmission electron microscopy to
visualize if cT3SS protein expression would results in the
formation of a T3SS-like structure(s) in bacterial membranes of
cT3SS-expressing E. coli. Interestingly, we detected channel-like
structures between the cytoplasm membrane and the outer
membrane in a small proportion of transformed E. coli (Fig. 5A–
C), whereas such structures were never detected in control bacteria
transformed with control empty pACYC184 and pBAD18
(Fig. 5D), suggesting that the structures were recombinant cT3SS.
Discussion
In the absence of a convenient tool to study cT3SS, we explored
the reconstitution of cT3SS in E. coli. We were able to clone all 6
cT3SS cluster into 3 vectors, and co-transform them and a cT3S
effector vector into E. coli. Whereas the expression of the effectors
in E. coli was expected to be driven by a promoter in the vector,
expression of genes in the cloned cT3SS clusters should be driven
by their own promoters. We detected the expression of 2 cT3SS
proteins, CT557 and CT672 in transformed E. coli (Fig. 2). Our
inability to analyze the expression of the remaining proteins was
due to high background of antibodies against chlamydial proteins.
While these antibodies are highly useful for analyzing chlamydial
protein expression in chlamydiae [27,44], their usefulness in
analyzing recombinant protein expression in E. coli is limited since
the immunogens used to generate the antibodies were recombi-
nant proteins carrying E. coli protein contaminants. Although only
two of the 37 proteins encoded by the cT3SS clusters could be
detected, the remaining 35 proteins were likely to be expressed in
E. coli since we detected the expression of mRNAs encoded by all
10 operons in the 6 cT3SS clusters (Fig. 3) and the detection of
T3SS-like structures in bacteria transformed with cT3SS expres-
sion vectors (Fig. 4).
Previous analyses have shown that promoters for 7 of the 10
cT3SS operons are active in E. coli [39]. The absence of the
CT717 mRNA expression in E. coli transformed with pcT3SS-C1/
C5/C6 in which cluster 5 is led by its own promoter (plus pcT3SS-
C2/C3 and pcT3SS-C4) demonstrated by our RT-PCR analysis
confirms non-recognition of the sole promoter of cluster 5 by the
E. coli transcriptional machinery as previously reported [39]. The
other two promoters that failed to function in E. coli in that study
[39] were an internal promoters upstream of CT559 in clusters 2
and the second internal promoter upstream of CT674. Thus, the
mRNAs for CT562 and CT674 detected in Fig. 3 are likely to
originate from the transcripts of the primary operons rather than
the secondary operons.
Despite of the evidence for cT3SS expression in E. coli, secretion
in the transformed bacteria was undetectable for any of the five
cT3S effectors analyzed (Fig. 4A,B,D). The reason for these
negative findings may be multi-factorial. First, even though RT-
PCR data suggest that all cT3SS genes are transcribed, their
expression levels may not be high enough to allow for the
production of enough cT3SS apparatuses in the fast-growing E.
coli to efficiently secrete effectors since the heterologous expression
still relied on the native cT3SS promoters, some which may
function inefficiently in the enterobacterium. Second, the efficien-
cy of biosynthesis of some cT3SS proteins might be low due to
possible rare codon use in E. coli, which limited the formation of
recombinant cT3SS, even if transcription occurred efficiently.
Third, the epitope tag added to the C-terminus of the effectors
may interfere with secretion even though the secretion signal is
known to reside within the N-terminus [1,6,22]. Fourth, assembly
of cT3SS proteins into a secretion apparatus in E. coli, an
unnatural environment for chlamydial proteins, may also be
insufficient. Finally, the recombinant cT3SS may not respond to
the experimental conditions for secretion induction in E. coli
regardless whether or not these conditions generate signals for
secretion in chlamydiae.
Channel-like structures were detected between the cytoplasm
membrane and outer membrane in a small number of bacteria
carrying the entire 6 cT3SS clusters using ultrathin section
transmission electron microscopy (Fig. 5). These structures were
never found in control bacteria transformed with empty vectors.
These findings indicate that the structures were formed by cT3SS
proteins albeit at low efficiency. Nevertheless, in the absence of
evidence for the secretion of cT3S effectors, it is not absolutely
certain whether these channels are complete or incomplete T3SS,
if at all. Demonstration of the existence of cT3SS proteins in the
channels will be essential to establish the channels’ identities.
Unfortunately, the anti-CT557 antibody that we used is unlikely to
be useful for characterization of the putative T3SS-like structures
using immunoelectronic microscopy because it lacks the capacity
to specifically detect signals in cT3SS-expressing E. coli in an
immunofluorescence assay (data not shown), despite its high
specificity shown in western blotting. Even if another antibody
recognizes CT557 in immunostaining, it might have no value for
analyzing cT3SS structures because CT557 is predicted to be a
dihydrolipoamide dehydrogenase, an unrelated homolog of which
the localization cannot be predicted. Furthermore, although
CT672 is a predicted cT3SS apparatus protein, the strong
nonspecific binding activity of the anti-CT672 (Fig. 2B) makes it
worthless for immunoelectronic microscopy. For these consider-
ations, we are performing epitope tagging for proteins predicted to
be in the cT3SS structure apparatus to characterize the cT3SS-
like structures in recombinant E. coli cells.
Supporting Information
Table S1 Primers for vector construction. Chlamydial
genomic DNA sequences are shown in lower cases. Sequences in
upper cases were added to create enzyme-cutting sites (non-italics)
and to facilitate digestion (italics).
(XLS)
Table S2 Sequencing primers. Number denotes position of
primer’s first base in the C. trachomatis D genome (accession #:
NC_000117).
(XLS)
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